A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2

The rapid expansion of the COVID-19 pandemic has made the development of a SARS-CoV-2 vaccine a global health and economic priority. Taking advantage of versatility and rapid development, three SARS-CoV-2 mRNA vaccine candidates have entered clinical trials with a two-dose immunization regimen. Howe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Commun
Autors principals: Huang, Qingrui, Ji, Kai, Tian, Siyu, Wang, Fengze, Huang, Baoying, Tong, Zhou, Tan, Shuguang, Hao, Junfeng, Wang, Qihui, Tan, Wenjie, Gao, George F., Yan, Jinghua
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7858593/
https://ncbi.nlm.nih.gov/pubmed/33536425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-021-21037-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars